Clinical Trial Update: A Study to Evaluate the Performance and Safety of Artelac Rebalance® Versus Vismed in the Management of Dry Eye [NA]

View source ↗

Summary

A head-to-head clinical trial evaluating Artelac Rebalance versus Vismed for dry eye has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Artelac Rebalance
• Vismed

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Dry Eye | NA | Status: WITHDRAWN